A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack

Marie Viprey,1,2 Maïlys Gouillet,3 Costanza Puppo,3 Anne Termoz,1,2 Claire Della Vecchia,2,3 Laurent Derex,2,4 Julie Haesebaert,1,2 Anne-Marie Schott,1,2 Marie Préau3 1Public Health Department, Hospices Civils de Lyon, Lyon, France; 2HESPER EA 7425, University of Lyon, University...

Full description

Bibliographic Details
Main Authors: Viprey M, Gouillet M, Puppo C, Termoz A, Della Vecchia C, Derex L, Haesebaert J, Schott AM, Préau M
Format: Article
Language:English
Published: Dove Medical Press 2020-07-01
Series:Patient Preference and Adherence
Subjects:
Online Access:https://www.dovepress.com/a-qualitative-study-of-barriers-and-facilitators-to-adherence-to-secon-peer-reviewed-article-PPA
_version_ 1818134240158547968
author Viprey M
Gouillet M
Puppo C
Termoz A
Della Vecchia C
Derex L
Haesebaert J
Schott AM
Préau M
author_facet Viprey M
Gouillet M
Puppo C
Termoz A
Della Vecchia C
Derex L
Haesebaert J
Schott AM
Préau M
author_sort Viprey M
collection DOAJ
description Marie Viprey,1,2 Maïlys Gouillet,3 Costanza Puppo,3 Anne Termoz,1,2 Claire Della Vecchia,2,3 Laurent Derex,2,4 Julie Haesebaert,1,2 Anne-Marie Schott,1,2 Marie Préau3 1Public Health Department, Hospices Civils de Lyon, Lyon, France; 2HESPER EA 7425, University of Lyon, University Claude Bernard Lyon 1, Lyon, France; 3GRePS, Lyon 2 University, Lyon, France; 4Comprehensive Stroke Center, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, FranceCorrespondence: Marie VipreyHospices Civils de Lyon, Pôle de Santé Publique, Bâtiment A, 6ème étage, 162, Avenue Lacassagne, Lyon 69003, FranceTel +33 4 72 11 53 02Email marie.viprey@chu-lyon.frPurpose: Secondary prevention medications (SPM) reduce the risk of ischemic stroke (IS) and transient ischemic attack (TIA) recurrence. However, approximately one-third of patients are estimated to be non-adherent. This qualitative study aimed to explore barriers and facilitators to adherence to SPM after IS or TIA.Patients and Methods: Thirty-six face-to-face semi-structured interviews were conducted with 14 TIA patients and 22 IS patients who self-administered their treatment 12 months after IS/TIA. A thematic analysis was performed.Results: Major facilitators to good adherence to SPM were the fear of stroke recurrence and the high level of trust in the prescribing physician. Barriers included a perceived lack and/or inappropriate timing of information about SPM, practical difficulties of taking some SPM (eg, inadequate packaging) and of implementing routines into their daily life.Conclusion: Information on SPM is inadequate in terms of quantity and timing both during the acute IS/TIA period and over the long term. Providing more tailor-made information at an opportune moment, in particular by promoting discussion with their general practitioner (GP) throughout the course of illness and recovery, is essential to ensure that patients are not left alone in the decision-making process regarding adherence to SPM.Keywords: medication adherence, stroke, transient ischemic attack, qualitative study
first_indexed 2024-12-11T09:05:28Z
format Article
id doaj.art-6957d28699414143976ecf979665213e
institution Directory Open Access Journal
issn 1177-889X
language English
last_indexed 2024-12-11T09:05:28Z
publishDate 2020-07-01
publisher Dove Medical Press
record_format Article
series Patient Preference and Adherence
spelling doaj.art-6957d28699414143976ecf979665213e2022-12-22T01:13:39ZengDove Medical PressPatient Preference and Adherence1177-889X2020-07-01Volume 141213122355519A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic AttackViprey MGouillet MPuppo CTermoz ADella Vecchia CDerex LHaesebaert JSchott AMPréau MMarie Viprey,1,2 Maïlys Gouillet,3 Costanza Puppo,3 Anne Termoz,1,2 Claire Della Vecchia,2,3 Laurent Derex,2,4 Julie Haesebaert,1,2 Anne-Marie Schott,1,2 Marie Préau3 1Public Health Department, Hospices Civils de Lyon, Lyon, France; 2HESPER EA 7425, University of Lyon, University Claude Bernard Lyon 1, Lyon, France; 3GRePS, Lyon 2 University, Lyon, France; 4Comprehensive Stroke Center, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, FranceCorrespondence: Marie VipreyHospices Civils de Lyon, Pôle de Santé Publique, Bâtiment A, 6ème étage, 162, Avenue Lacassagne, Lyon 69003, FranceTel +33 4 72 11 53 02Email marie.viprey@chu-lyon.frPurpose: Secondary prevention medications (SPM) reduce the risk of ischemic stroke (IS) and transient ischemic attack (TIA) recurrence. However, approximately one-third of patients are estimated to be non-adherent. This qualitative study aimed to explore barriers and facilitators to adherence to SPM after IS or TIA.Patients and Methods: Thirty-six face-to-face semi-structured interviews were conducted with 14 TIA patients and 22 IS patients who self-administered their treatment 12 months after IS/TIA. A thematic analysis was performed.Results: Major facilitators to good adherence to SPM were the fear of stroke recurrence and the high level of trust in the prescribing physician. Barriers included a perceived lack and/or inappropriate timing of information about SPM, practical difficulties of taking some SPM (eg, inadequate packaging) and of implementing routines into their daily life.Conclusion: Information on SPM is inadequate in terms of quantity and timing both during the acute IS/TIA period and over the long term. Providing more tailor-made information at an opportune moment, in particular by promoting discussion with their general practitioner (GP) throughout the course of illness and recovery, is essential to ensure that patients are not left alone in the decision-making process regarding adherence to SPM.Keywords: medication adherence, stroke, transient ischemic attack, qualitative studyhttps://www.dovepress.com/a-qualitative-study-of-barriers-and-facilitators-to-adherence-to-secon-peer-reviewed-article-PPAmedication adherencestroketransient ischemic attackqualitative study
spellingShingle Viprey M
Gouillet M
Puppo C
Termoz A
Della Vecchia C
Derex L
Haesebaert J
Schott AM
Préau M
A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
Patient Preference and Adherence
medication adherence
stroke
transient ischemic attack
qualitative study
title A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
title_full A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
title_fullStr A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
title_full_unstemmed A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
title_short A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
title_sort qualitative study of barriers and facilitators to adherence to secondary prevention medications among french patients suffering from stroke and transient ischemic attack
topic medication adherence
stroke
transient ischemic attack
qualitative study
url https://www.dovepress.com/a-qualitative-study-of-barriers-and-facilitators-to-adherence-to-secon-peer-reviewed-article-PPA
work_keys_str_mv AT vipreym aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT gouilletm aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT puppoc aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT termoza aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT dellavecchiac aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT derexl aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT haesebaertj aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT schottam aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT preaum aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT vipreym qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT gouilletm qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT puppoc qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT termoza qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT dellavecchiac qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT derexl qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT haesebaertj qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT schottam qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack
AT preaum qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack